Skip to main content

New Enterprise Associates — Portfolio, Page 19

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

638
Companies
$26.4B
Total invested
$54.3M
Avg. check
66
Industries
Health Care 8Biotechnology 7Therapeutics 5Artificial Intelligence (AI) 5Medical 5Pharmaceutical 4+60 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 433456 of 638
Synlogic
September 2023

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Biotechnology · Cambridge$21.0M Post Ipo Equity
Meeno
September 2023

Meeno offers an AI relationship mentoring app targeting young adults.

Artificial Intelligence (AI) · San Francisco$3.9M Seed
ThirdLove
August 2023

ThirdLove is a women’s lifestyle brand that offers a range of lingerie and underwear.

E-Commerce · San Francisco$12.0M Debt Financing
Fizz
August 2023

Fizz is a social platform that serves as a private discussion forum and news feed for schools.

Communities · Palo Alto$25.0M Series B
Inozyme
July 2023

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Biotechnology · Boston$60.0M Post Ipo Equity
Nexo Therapeutics
July 2023

Nexo Therapeutics offers treatments for some of cancer's most intractable targets.

Biotechnology · Littleton$60.0M Series A
Gossamer Bio
July 2023

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Biotechnology · San Diego$212.0M Post Ipo Equity
Tagworks Pharmaceuticals
June 2023

Tagworks Pharmaceuticals is a privately held biotech company

Biotechnology · Nijmegen$65.0M Series A
Snowplow
June 2023

Snowplow is the customer context layer that transforms raw behavioral data into real-time context for AI agents, ML, and advanced analytics

Agentic AI · LondonSeries Unknown
Revelle Aesthetics
June 2023

Revelle Aesthetics features a team of the brightest and most passionate minds in the medical device and aesthetics industries.

Health Care · Mountain View$30.0M Series Unknown
Kira
May 2023

Kira is an AI company that creates innovative tools and solutions to support educators, students, and administrators.

Artificial Intelligence (AI) · Palo Alto$15.0M Series A
Weaviate
April 2023

Weaviate powers semantic search, RAG, and intelligent agents in one AI-native vector database platform

AI Infrastructure · Amsterdam$50.0M Series B
SimpleRose
April 2023

SimpleRose is a technology company that allows customers to optimize and accelerate decision-making.

Enterprise Applications · Saint Louis$23.0M Series A
Yumi
February 2023

Yumi offers a science-based early childhood meal delivery program.

Baby · Los AngelesSeries Unknown
GLAMSQUAD
January 2023

GLAMSQUAD is a next-generation, omni-channel beauty brand offering services as well as hair styling and makeup products.

Beauty · New YorkPrivate Equity
Candy Digital
January 2023

Candy Digital is an NFT company that allows MLB fans to buy and trade officially licensed nonfungible tokens.

Blockchain · New York$38.4M Series A
Launchpad Therapeutics
December 2022

Launchpad Therapeutics operates as an antibody-focused precision oncology company.

Life Science · San Francisco$10.0M Series Unknown
DataVisor
December 2022

DataVisor is a fraud detection company powered by transformational AI technology.

Artificial Intelligence (AI) · Mountain View$40.0M Series Unknown
Deep Voodoo
December 2022

Deep Voodoo is an AI media and entertainment technology platform.

Gaming · Belfast$20.0M Seed
Eargo
November 2022

Eargo specializes in the design and development of hearing aids.

Health Care · San Jose$29.3M Post Ipo Equity
Escient Pharmaceuticals
November 2022

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Biotechnology · San Diego$120.0M Series C
Inversago Pharma
October 2022

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

Biopharma · Montréal$69.3M Series C
Expel
October 2022

Expel is a security operations provider that offers managed detection and response, remediation, phishing support, and threat hunting.

Cloud Security · Herndon$31.0M Series E
Willow
September 2022

Willow is a women's healthcare company that develops pumping bras and breast pumps for women.

Commercial · Mountain ViewSeries D

Where New Enterprise Associates invests

Health Care8
Biotechnology7
Therapeutics5
Artificial Intelligence (AI)5
Medical5
Pharmaceutical4

About New Enterprise Associates's portfolio

How many companies has New Enterprise Associates invested in?

New Enterprise Associates has invested in 638 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does New Enterprise Associates invest in?

New Enterprise Associates's top investment sectors include Health Care, Biotechnology, Therapeutics, Artificial Intelligence (AI), Medical. The firm invests across 66 different industry categories.

What is New Enterprise Associates's largest investment?

Among tracked funding rounds, Gossamer Bio received $212.0M in a Post Ipo Equity round. New Enterprise Associates's total known invested capital is $26.4B.

What is the average investment size for New Enterprise Associates?

New Enterprise Associates's average investment size is $54.3M across its portfolio of 638 companies.

What are New Enterprise Associates's most recent investments?

Recent New Enterprise Associates portfolio additions include Synlogic, Meeno, ThirdLove, Fizz, Inozyme. These companies were founded in 2020 or later.

Reach the founders behind these 638 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →